Rap1 Regulates Hematopoietic Stem Cell Survival and Affects Oncogenesis and Response to Chemotherapy
Ekta Khattar,Kyaw Ze Ya Maung,Chen Li Chew,Arkasubhra Ghosh,Michelle Meng Huang Mok,Pei Lee,Jun Zhang,Wei Hong Jeff Chor,Gökhan Cildir,Chelsia Qiuxia Wang,Nur Khairiah Mohd-Ismail,Desmond Wai Loon Chin,Soo Chin Lee,Henry Yang,Yong-Jae Shin,Do-Hyun Nam,Liming Chen,Alan Prem Kumar,Lih Wen Deng,Masahito Ikawa,Jayantha Gunaratne,Motomi Osato,Vinay Tergaonkar
DOI: https://doi.org/10.1038/s41467-019-13082-9
IF: 16.6
2019-01-01
Nature Communications
Abstract:Increased levels and non-telomeric roles have been reported for shelterin proteins, including RAP1 in cancers. Herein using Rap1 null mice, we provide the genetic evidence that mammalian Rap1 plays a major role in hematopoietic stem cell survival, oncogenesis and response to chemotherapy. Strikingly, this function of RAP1 is independent of its association with the telomere or with its known partner TRF2. We show that RAP1 interacts with many members of the DNA damage response (DDR) pathway. RAP1 depleted cells show reduced interaction between XRCC4/DNA Ligase IV and DNA-PK, and are impaired in DNA Ligase IV recruitment to damaged chromatin for efficient repair. Consistent with its role in DNA damage repair, RAP1 loss decreases double-strand break repair via NHEJ in vivo, and consequently reduces B cell class switch recombination. Finally, we discover that RAP1 levels are predictive of the success of chemotherapy in breast and colon cancer.